Current and emerging therapies for eosinophilic esophagitis

Area of Science:

• Gastroenterology
• Immunology
• Allergy

Background:

• Eosinophilic esophagitis (EoE) is a Type-2 chronic inflammatory food antigen-driven disease of the esophagus.
• Characterized by eosinophilic inflammation and symptoms, EoE incidence and prevalence have risen significantly.
• There is a critical need for less burdensome, approved treatment options for EoE.

Purpose of the Study:

• To elucidate the pathophysiology and diagnostic criteria for EoE.
• To review current therapeutic strategies for managing EoE.
• To explore novel and emerging treatments for this condition.

Main Methods:

• A comprehensive literature search was conducted in a medical database.
• Articles focusing on the treatment of Eosinophilic Esophagitis were included.

Main Results:

• Dietary elimination, topical corticosteroids, and proton-pump inhibitors show efficacy in diverse patient populations.
• Emerging therapies include novel topical corticosteroids and biologics targeting Type 2 inflammation.
• Data suggests personalized treatment approaches are becoming increasingly feasible.

Conclusions:

• EoE is a chronic, potentially debilitating disorder with significant long-term implications.
• While no therapies are currently FDA-approved in the US, numerous promising treatments are under development.
• Shared decision-making is crucial for guiding treatment choices and managing the growing burden of EoE.